Assessment of the kynurenine pathway in humans: I. Normal plasma values, ethnic differences and their clinical implications

International Congress Series

Volumn 1304, Issue , 2007, Pages 335-343

  Badawy, Abdulla A B ^a   Morgan, Christopher J ^b   Turner, Jennifer A ^c   Dougherty, Donald M ^d   Marsh, Dawn M ^d   Mathias, Charles W ^d   Addicott, Meredith A ^d   Jagar, Ashley A ^e  

^a CARDIFF METROPOLITAN UNIVERSITY   (United Kingdom)

^b UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

^c CARDIFF UNIVERSITY   (United Kingdom)

^d WAKE FOREST SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF TEXAS   (United States)

Author keywords

3 Hydroxyanthranilic acid; 3 Hydroxykynurenine; Anthranilic acid; Kynurenic acid; Kynurenine; Kynurenine pathway; Tryptophan; Xanthurenic acid

Indexed keywords

EID: 35948992937     PISSN: 05315131     EISSN: None     Source Type: Book Series    
DOI: 10.1016/j.ics.2007.07.034     Document Type: Article

References (24)

1. Badawy A.A.-B. Tryptophan metabolism and alcoholism. In: Preedy V.R., and Watson R.R. (Eds). Comprehensive Handbook of alcohol Related Pathology Vol. 3 (2005) 1303-1314 Ch 99
2. Young S.N., and Sourkes T.L. Tryptophan catabolism by tryptophan pyrrolase in rat liver. Journal of Biological Chemistry 250 (1975) 5009-5014
3. Badawy A.A.-B. Minireview: the functions and regulation of tryptophan pyrrolase. Life Sciences 21 (1977) 755-767
4. Taylor M.W., and Feng G. Relationship between interferon-γ, indoleamine dioxygenase, and tryptophan catabolism. FASEB Journal 5 (1991) 2516-2522
5. Michael A.F., et al. Tryptophan metabolism in man. Journal of Clinical Investigation 43 (1964) 1730-1746
6. Price J.M., Brown R.R., and Yess N. Testing the functional capacity of the tryptophan-niacin pathway in man by analysis of urinary metabolites. Advances in Metabolic Disorders 2 (1965) 159-225
7. 6 depletion in man: urinary excretion of quinolinic acid and niacin metabolites. Journal of Nutrition 87 (1965) 419-423
8. Chiarugi A., et al. Comparison of the neurochemical and behavioral effects resulting from the inhibition of kynurenine hydroxylase and/or kynureninase. Journal of Neurochemistry 65 (1995) 1176-1183
9. Heyes M.P., and Morrison P.F. Quantification of local de novo synthesis versus blood contribution to quinolinic acid concentrations in brain and systemic tissues. Journal of Neurochemistry 68 (1997) 280-288
10. Friedman M.J., et al. Altered conversion of tryptophan to kynurenine in newly abstinent alcoholics. Biological Psychiatry 23 (1988) 89-93
11. Forrest C.M., et al. Tryptophan loading induces oxidative stress. Free Radiacal Research 38 (2004) 1167-1171
12. Molnár-Perl I. Advances in the analysis of tryptophan and its related compounds by chromatography. Advances in Experimental Medicine and Biology 467 (1999) 801-816
13. Neurauter G., et al. Effective antiretroviral therapy reduces degradation of tryptophan in patients with HIV-1 infection. Advances in Experimental Medicine and Biology 527 (2003) 317-323
14. Joseph M.H., and Risby D. The determination of kynurenine in plasma. Clinica Chimica Acta 63 (1975) 197-204
15. Fuchs D., et al. Increased endogenous interferon-gamma and neopterin correlate with increased degradation of tryptophan in human immunodeficiency virus type 1 infection. Immunology Letters 28 (1991) 207-212
16. Forrest C.M., et al. Kynurenine and neopterin levels in patients with rheumatoid arthritis and osteoporosis during drug treatment. Advances in Experimental Medicine and Biology 527 (2003) 287-295
17. Nishizawa S., et al. Differences between males and females in rates of serotonin synthesis in humans brain. Proceedings of the National Academy of Sciences of the United States of America 94 (1997) 5308-5313
18. Stone T.W., and Connick J.H. Commentary: quinolinic acid and other kynurenines in the central nervous system. Neuroscience 15 (1985) 597-617
19. Moroni F., et al. Increase in the content of quinolinic acid in cerebrospinal fluid and frontal cortex of patients with hepatic failure. Journal of Neurochemistry 47 (1986) 1667-1671
20. Heyes M.P., et al. Quinolinic acid and kynurenine pathway metabolism in inflammatory and non-inflammatory neurological disease. Brain 115 (1993) 1249-1273
21. Sardar A.M., Bell J.E., and Reynolds G.P. Increased concentrations of the neurotoxin 3-hydroxykynurenine in the frontal cortex of HIV-1-positive patients. Journal of Neurochemistry 64 (1995) 932-935
22. Morgan P.F. Is quinolinic acid an endogenous excitotoxin in alcohol withdrawal?. Medical Hypotheses 36 (1991) 118-121
23. Bender D.A. Biochemistry of tryptophan in health and disease. Molecular Aspects of Medicine 6 (1982) 101-197
24. Tanizawa K., and Soda K. Purification and properties of pig liver kynureninase. Journal of Biochemistry (Tokyo) 85 (1979) 901-906